Cells. All cells were prepared at room temperature under sterile conditions. Spleen, mesenteric lymph node, and thymus cells were prepared by passing the cells of these organs through a 200-mesh stainless steel screen, in balanced salt solution (BSS) containing in most cases 10% fetal calf serum. Bone marrow cells were extracted from the femurs by cutting open the ends of the femurs, attaching a 25 gauge-needle to one end, and pushing the cells out at the other end with BSS containing 10% fetal calf serum. The cell clumps were then dissociated by pipetting up and down in a 10-ml plastic pipette (Falcon no. 7551, Falcon Plastics, Oxnard, Calif.) 10 times. Thoracic duct cells were obtained by overnight drainage of the thoracic duct following the method of Sprent (8) . Peripheral blood lymphocytes were obtained from heparinized (Liquemin, Roche, Basel, Switzerland) blood. Erythrocytes were, at least to a larger part, removed by lysis for 3 rain at 37°C in 0.83% NH4C1. From all cell preparations possible cell clumps were allowed to settle for 5 rain at 1 g. All cell suspensions were then washed twice over a layer of fetal calf serum (centrifugation for 10 min at 200 g) and finally resuspended in RPMI 1640 tissue culture medium (Grand Island Biological Co., Grand Island, N. Y.) (see below). Viable cells were determined by the trypan-blue exclusion method. Nucleated cells were counted in Tiirk's solution. Viabilities ranged for spleen between 75 and 90%, for lymph node between 85 and 95%, for all other cell preparations above 90%.
Whenever murine thymus cells were used as growth-supporting cells in culture (2) they were obtained from 4-wk old syngeneic or allogeneic mice and passed twice through columns of nylon wool (Fenwal Laboratories, Bern, Switzerland) (9) . This double passage through nylon wool was mandatory to remove contaminating LPS-reactive B cells which developed into IgM-secreting PFC if they were left in the thymus cell preparations ( [2] , see also Results with thymus cells). Recently we have found (Lernhardt, W., and F. Melchers. Manuscript in preparation) that xenogeneic thymus cells, i.e. from 4-to 6-wk old Lewis-strain rats (Institut fiir Biologisch-Medizinische Forschung AG), support the growth of murine B cells just as efficiently as murine thymus cells. This offers the advantage that more cells are readily available. Thymus cells from rat also do not have to be passed through nylon wool, since rat thymus either does not contain LPS-reactive B cells developing into IgM-secreting PFC, or, if they do, these PFC are not detected in the protein A-SRC plaque assay with the motise Ig-specific antibodies. We indicate in the Results section which source of thymus cells has been used as growth support in the experiments.
Culture Medium. RPMI 1640 medium was used fresh (not older than 2 too) from Microbiological Associates, Bethesda, Md., or from Bio-Cult, Irvine, Scotland. Glutamine (2 raM), penicillin, and streptomycin (5,000 IU/ml each), HEPES-buffer (10 raM) pH 7.3; 2-mercaptoethanol (5 × 10 -5 M), and fetal calf serum (10%), batch K 255701 D (Bio-Cult), specifically tested for growth-supporting properties and for low or undetectable endogenous mitogenic activities (4), were added. Cells were cultured in 5-ml plastic tubes in O.2-ml aliquots (Falcon no. 2058, Falcon Plastics). At the termination of culture, 5 ml cold BSS was added, the cells were spun for 10 rain at 200 g, and resuspended in appropriate volumes of cold BSS for plaque assay.
Mitogens. LPS-S (EDTEN 18735 and $495/188049) was kindly prepared for us by Doctors C.
Galanos and O. Lfideritz, Max-Planck-Institut fiir Immunbiologie, Freiburg i.Br., West-Germany. It was used in culture at 50 ~tg/ml (10) . Escherichia coli lipeprotein (6), a gift of Dr. V.
Braun, Mikrobiologie II, Universit~it Tfibingen, Tiibingen, West-Germany, was used at 2 ~g/ml.
Plaque Assay for Ig-Seereting Cells. A modified hemolytic plaque assay with protein A-coated SRC and mouse Ig-specific antisera as developing antibodies in the presence of complement was employed to detect and enumerate Ig-secreting cells (7), IgM-secreting PFC were scored throughout the experiments reported in this paper. The IgM-specific antisera used in the plaque assay were raised by repeated injections of 0.5-1 mg purified MOPC 104 E 19S IgM (11) in Freund's incomplete adjuvants. The antisera detected/~H and kL chains-, but not 7H-or all-or KL-chainsecreting cells as tested in plaque assays with the corresponding myeloma tumor cell suspensions. Protein A used in coating of SRC was obtained from Dr. H. Wigzell, Biomedicum, University of Uppsala, Uppsala, Sweden. Complement, diluted appropriately with BSS, was from Bio-Cult.
In the experiments where IgG-secreting PFC were scored, a mixture of rabbit antibodies raised against the mouse myeloma proteins MOPC 21 (7S IgG1; K,Tl) and Adj-PC-5 (7S IgG2; K,T2) was used to develop the plaques.
Results
In all experiments reported here the frequency of mitogen reactive B cells was determined by measuring the number of responding cultures, i.e. generating an IgM-secreting PFC response, at dilutions limiting the number of reactive B cells to around one. According to Poisson's distribution one reactive B cell is present in that number of cultured cells which will let 63% of all cultures grow into IgM-secreting PFC.
The number of cells limiting the mitogen-reactive B cells in the different cell preparations to approximately one per culture, was first determined in screening experiments by 3.3-fold-serial dilutions from 1 × 10 s cells to one cell per culture. All cultures were kept in medium containing the constant number of 3 × l0 s thymus cells per milliliter (see Materials and Methods). 10 cultures were assayed at each cell dilution. Since the doubling time of mitogen-activated B cells is 18 h, cultures yielding more than 15 IgM-secreting PFC at day 5 were scored as positive, responding cultures.
In the range of cell concentrations where the IgM-PFC responses were found to become fluctuating, indicating that the reactive B cells had become limiting, more narrow differences of cell concentrations were tested. Usually, 40 cultures each were set up at 5-10 cell concentrations within a range yielding between 10 and 90% nonresponding cultures. Again, cultures which yielded more than 15 IgM-PFC at day 5 were scored as positive, responding cultures. In most experiments a discontinuous distribution of the number of IgM-PFC per culture was found in cultures at cell concentrations where the responses were fluctuating. Many cultures had clone sizes of IgM-PFC around 60 which were of the size expected from our previous results (2) . The logarithm of the fraction of nonresponding cultures obtained with different cell concentrations was then plotted against the corresponding cell numbers in culture. The number of cultured cells containing one mitogen-reactive B cell was extrapolated from these data as that number of cells with which 37% of all cultures did not respond by an IgM-PFC response. If a linear degression of the logarithm of the fraction of nonresponding cultures was found with increasing numbers of cells in the cultures, this was an indication that the responding B cells had been limiting in the cultures. Table I were diluted in medium containing 3 × 106 thymus cells per ml to spleen cell concentrations limiting the number of responding B cells to around one and grown in the presence of LPS. Spleen cells from five of these inbred strains of mice were also grown in the presence of another B-cell mitogen, E. coli lipoprotein. Fig. 1 shows two representative experiments demonstrating that mitogen-reactive B cells were limiting in these cultures. Frequencies of mitegen-reactive B cells were calculated from the number of cultured cells which yielded in 63% of all cultures an IgM-PFC response, and, thus, contained one mitogen-reactive B cell. The frequency determinations for LPS-reactive and for lipoprotein-reactive B cells in spleen are summarized in Table I. LPS and lipoprotein-reactive B cells were found in high frequencies in spleen of most inbred strains of mice which we tested, i.e. one reactive B cell in between 6 and 20 spleen cells. If we assume that in all these spleen cell preparations, including those of BALB/c nu/nu origin (12) half of the cells are B cells, then one mitogen-reactive cell was found among three to seven splenic B cells. Spleen cells from normal, T-cell-containing and from nu/nu BALB/c-mice, lacking Fig. 1 ). ND, not done. 
Frequencies of LPS-and of Lipoprotein-Reactive B Cells in Spleen of Different Inbred Strains of Mice. Spleen cells of 6-to 8-wk old mice of inbred strains listed in

MITOGEN-REACTIVE B CELLS IN MICE
Frequencies of LPS-and of Lipoprotein-Reactive B Cells in Spleen of C3H/Tif
Mice of Different Age. The frequencies of LPS-and of lipoprotein-reactive B cells were determined in spleen cells of C3Hfrif mice at different ages. Newborn-, 2-wk, 6-to 8-wk, 6-, 11-, and 19-mo old mice were compared. Fig. 2 summarizes the results. The highest frequencies of LPS-and of lipoproteinreactive B cells were found in 6-to 8-wk old mice. The relative frequencies of LPS-and of lipoprotein-reactive cells did not change significantly at any age. At birth, 1 reactive cell was found in 30-50 spleen cells. Old mice (11 mo of age or older) had less than 5% of the number of mitogen-reactive B cells found at 6-8 wk of age. In all experiments the reactive B cells were limiting in the cultures.
Frequencies of LPS-Reactive B Cells in Different Lymphoid Organs. Frequencies of LPS-reactive cells were determined in mesenteric lymph
node, bone marrow, thymus, thoracic duct, and peripheral blood cells of 6-to 8-wk old mice of inbred strains of mice listed in Table II . The LPS-reactive B cells were limiting in all experiments. Mesenteric lymph nodes had numbers of LPSreactive cells very similar to spleen (see Table I ). In contrast to the other cell sources, bone marrow cells are heterogeneous in their response to LPS. Small cells of bone marrow yield an immediate IgM-PFC response, usually measured at day 5 of culture. Large cells of bone marrow develop an IgM-PFC response which is barely detectable at day 5 and which is measured at day 8-10 of culture Mitogen reactivity is most probably a function of the expression of mitogen receptors on the surface of B cells. These mitogen receptors must be distinct from Ig molecules, but may be functionally and structurally linked to them (17) .
Our results show that the proportion of LPS-and of lipoprotein-reactive B cells within the total population of B cells changes with age. At 6-8 wk of age a large proportion of all B cells, but not all of them, are reactive to LPS and to lipoprotein. This suggests that other B-cell mitogens exist which stimulate those B-cell populations which are not stimulated by LPS or lipoprotein. Candidates for these other B-cell mitogens are other external mitogens as well as internal mitogens (factors) produced by either T cells or macrophages' (18, 19) . One B cell may possess more than one mitogen receptor (20) . On the other hand, it also appears likely that mitogen-reactive B cells form only partially cross-reactive subpopulations of B cells (21) . We are currently investigating how many of the LPS-reactive B cells are also lipoprotein-reactive, and how many of them belong to noncross-reacting populations of B cells.
We assume that each of these different mitogen-reactive B-cell subpopulations express the whole repertoire of v-region sets on Ig molecules. Mitogens can, therefore, be used to analyze the total v-region repertoire of B cells by stimulating all mitogen-reactive cells to Ig secretion. In this way, we have analyzed the repertoire of v regions on Ig molecules which are detected by antigen-specific assays for B-cell Ig (Succeeding publication).
Frequency determinations of reactive cells in vitro can be taken as quantitative analyses of the capacity of a given cell population to react to a stimulating agent. C3H/HeJ-mice are genetically nonresponsive to LPS, but normally respensive to lipoprotein (6, 13, 14) . Consequently, we found no LPS-reactive B cells detectable above background while normal numbers of lipoprotein-reactive cells were present. The background activities of growing B cells in our cultures without mitogen are most probably due to B-cell mitogens in fetal calf serum (15) . Our frequency analyses show a marked lower frequency for beth LPS-and for lipoprotein-reactive B cells in SJL mice.
We have also determined the frequency of mitogen-reactive B cells in different lymphoid organs of the mouse. LPS-reactive B cells were known to exist in mesenteric lymph nodes, thoracic duct, and bone marrow. In thymus and peripheral blood, LPS-reactive B cells yielding an Ig-secreting PFC response had not been found previously with less sensitive methods of in vitro culture. Thymus cells, not passed over nylon wool, contained one to two LPS-reactive B cells in 105 cells. This certainly constitutes the minimal estimate of the number of B cells in thymus, since we do not know at present how many B cells with other mitogen reactivities reside in thymus. B-cell contamination in thymus is, therefore, so extensive that it must be considered to interfere in all experiments where thymus cells are assayed for the presence, the synthesis and the biological activities of B-cell-like Ig (22, 23) . The number of LPS-and of lipoprotein-reactive B cells in spleen was dependent upon the age of the mouse. Newborn spleen contained approximately 10% of the number of reactive cells found at 6-to 8-wk of age. From there the frequencies declined again to drop below 5% of the maximal number at ages beyond 11 mo.
LPS-reactive B cells yielding IgM-and IgG-PFC responses could be found in mesenteric lymph nodes, bone marrow, thymus, thoracic duct, and peripheral blood of 6-to 8-wk old mice. Their frequencies were one in three to five lymph node cells, 1 in 50 to 100 bone marrow cells, one in 105 thymus cells, and 1 in 20 to 40 thoracic duct or peripheral blood cells.
